BioSpace News Archive

Policy

Ceterix Orthopaedics Awarded New U.S. Patent for Circumferential Suturing Method in Meniscus Repair

New Patent Further Protects the Unique Circumferential Compression Stitch Method and Expands the Company’s Intellectual Property Portfolio for Orthopaedic Applications

July 12, 2018
·
3 min read
Business

X4 Pharmaceuticals Appoints Michael Wyzga as Chair of Board of Directors

Mr. Wyzga brings leadership experience, including in rare diseases and cancer

July 12, 2018
·
2 min read
Drug Development

Seattle Genetics Announces First Patient Dosed in Phase 2 innovaTV 207 Trial Evaluating Tisotumab Vedotin in Multiple Solid Tumors

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced dosing of the first patient in the phase 2 innovaTV 207 clinical trial.

July 12, 2018
·
5 min read
Policy

Therapix Biosciences Signs Term Sheet for the Transfer of Non-Pain Cannabinoid-Based Drug Pipeline Assets to Cure Pharmaceutical

Therapix Biosciences Ltd. announced that it has signed a non-binding term sheet with CURE Pharmaceutical for the transfer to CURE of the non-pain assets of Therapix, subject to the fulfillment of the certain conditions.

July 12, 2018
·
5 min read
Policy

Mesothelioma Victims Center Extends Services to a Railroad Conductor or Engineer with Mesothelioma- Call for On-The-Spot Access To The Nation’s Best Lawyers For Better Compensation Results

The Mesothelioma Victims Center is appealing to a railroad conductor or engineer who has recently been diagnosed with mesothelioma to call them anytime at 800-714-0303 to ensure on-the-spot access to some of the nation’s most experienced mesothelioma lawyers who consistently get the best possible financial compensation results for their clients.

July 12, 2018
·
3 min read
Business

Freenome’s IMPACT Advisory Board Brings Strategic Insight and Real-World Experience to AI-Genomics Cancer Tests

Freenome announced the creation of its IMPACT Advisory Board, a group tasked with helping Freenome’s leadership team optimize the company’s short- and long-term strategies, including those for its first commercial launch.

July 12, 2018
·
3 min read
Pharm Country

Navitas Life Sciences, a TAKE Solutions Enterprise, has been named as a Leader in IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment

Navitas Life Sciences announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment

July 12, 2018
·
4 min read
Evident launches Evident Design Services to Take the Industry from Traditional to Digital

Evident announces new service and strategic partnership with Amann Girrbach to support the increasing demand of digital dentistry

July 12, 2018
·
2 min read
Pharm Country

New Research Finds About Half of Parents Use Cell Phones While Driving with Young Children in the Car

Study of Adults Across the U.S. Also Revealed Risky Behaviors Associated with Distracted Driving

July 12, 2018
·
5 min read
Policy

CStone’s PD-1 inhibitor CS1003 receives clinical trial approval in China

CStone Pharmaceuticals announced that the China National Drug Administration (CNDA) has approved the first clinical trial application (CTA) in China for CS1003

July 12, 2018
·
3 min read